I think the difference with the project this time is that the past two entities spent significant funds to develop then ATI picked it up "cheap".No doubt it would not be viable starting from scratch though.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025